The estimated Net Worth of Jorge R. Taborga is at least $6.77 Milione dollars as of 11 March 2019. Mr Taborga owns over 19,796 units of Omnicell stock worth over $1,508,484 and over the last 12 years he sold OMCL stock worth over $5,262,192.
Mr has made over 18 trades of the Omnicell stock since 2014, according to the Form 4 filled with the SEC. Most recently he sold 19,796 units of OMCL stock worth $1,660,093 on 11 March 2019.
The largest trade he's ever made was exercising 25,979 units of Omnicell stock on 6 June 2016 worth over $1,118,916. On average, Mr trades about 4,256 units every 37 days since 2013. As of 11 March 2019 he still owns at least 35,024 units of Omnicell stock.
You can see the complete history of Mr Taborga stock trades at the bottom of the page.
Jorge R. Taborga is the Exec. VP of Engineering & Integration Management Officer at Omnicell.
Mr Taborga is 62, he's been the Exec. VP of Engineering & Integration Management Officer of Omnicell since . There are 7 older and 11 younger executives at Omnicell. The oldest executive at Omnicell, Inc. is Sara White, 74, who is the Independent Director.
Over the last 21 years, insiders at Omnicell have traded over $118,258,750 worth of Omnicell stock and bought 526,030 units worth $5,215,749 . The most active insiders traders include William H Jr Younger, Randall A Lipps e Benjamin A Horowitz. On average, Omnicell executives and independent directors trade stock every 10 days with the average trade being worth of $482,255. The most recent stock trade was executed by Christine Marie Mellon on 9 June 2023, trading 7,951 units of OMCL stock currently worth $581,536.
since 1992, omnicell has been creating new efficiencies to improve patient care, anywhere it is delivered. omnicell is a leading supplier of comprehensive automation and business analytics software for patient-centric medication and supply management across the entire health care continuum—from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. omnicell’s automated hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. our supply management systems promote greater cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. omnicell® products range from high-security, closed-cabinet systems and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room. more than 3,200 customers worldwide have utilized omnice
Omnicell executives and other stock owners filed with the SEC include: